UNITED STATES CELLULAR CORP
For the period ended Dec 31, 2023. Filed Feb 16, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 16, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Supplemental Information Relating to Non-GAAP Financial Measures
UScellular sometimes uses information derived from consolidated financial information but not presented in its financial statements prepared in accordance with GAAP to evaluate the performance of its business. Certain of these measures are considered “non-GAAP financial measures” under U.S. Securities and Exchange Commission Rules. Specifically, UScellular has referred to the following measures in this Form 10-K Report:
EBITDA
Adjusted EBITDA
Adjusted OIBDA
Free cash flow
Following are explanations of each of these measures:
EBITDA, Adjusted EBITDA and Adjusted OIBDA
EBITDA, Adjusted EBITDA and Adjusted OIBDA are defined as Net income adjusted for the items set forth in the reconciliation below. EBITDA, Adjusted EBITDA and Adjusted OIBDA are not measures of financial performance under GAAP and should not be considered as alternatives to Net income or Cash flows from operating activities, as indicators of cash flows or as measures of liquidity. UScellular does not intend to imply that any such items set forth in the reconciliation below are non-recurring, infrequent or unusual; such items may occur in the future.
Management uses Adjusted EBITDA and Adjusted OIBDA as measurements of profitability, and therefore reconciliations to applicable GAAP income measures are deemed appropriate. Management believes Adjusted EBITDA and Adjusted OIBDA are useful measures of UScellular’s operating results before significant recurring non-cash charges, nonrecurring expenses, gains and losses, and other items as presented below as they provide additional relevant and useful information to investors and other users of UScellular’s financial data in evaluating the effectiveness of its operations and underlying business trends in a manner that is consistent with management’s evaluation of business performance. Adjusted EBITDA shows adjusted earnings before interest, taxes, depreciation, amortization and accretion, gains and losses, and expenses related to the strategic alternatives review of UScellular, while Adjusted OIBDA reduces this measure further to exclude Equity in earnings of unconsolidated entities and Interest and dividend income in order to more effectively show the performance of operating activities excluding investment activities. The following tables reconcile EBITDA, Adjusted EBITDA and Adjusted OIBDA to the corresponding GAAP measures, Net income and Operating income.
| 2023 | 2022 | |
|---|---|---|
| (Dollars in millions) | ||
| Net income (GAAP) | $58 | $35 |
| Add back: | ||
| Income tax expense | 53 | 37 |
| Interest expense | 196 | 163 |
| Depreciation, amortization and accretion | 656 | 700 |
| EBITDA (Non-GAAP) | 963 | 935 |
| Add back or deduct: | ||
| Expenses related to strategic alternatives review | 8 | — |
| Loss on impairment of licenses | — | 3 |
| (Gain) loss on asset disposals, net | 17 | 19 |
| (Gain) loss on sale of business and other exit costs, net | — | (1) |
| (Gain) loss on license sales and exchanges, net | (2) | — |
| Adjusted EBITDA (Non-GAAP) | 986 | 956 |
| Deduct: | ||
| Equity in earnings of unconsolidated entities | 158 | 158 |
| Interest and dividend income | 10 | 8 |
| Adjusted OIBDA (Non-GAAP) | 818 | 790 |
| Deduct: | ||
| Depreciation, amortization and accretion | 656 | 700 |
| Expenses related to strategic alternatives review | 8 | — |
| Loss on impairment of licenses | — | 3 |
| (Gain) loss on asset disposals, net | 17 | 19 |
| (Gain) loss on sale of business and other exit costs, net | — | (1) |
| (Gain) loss on license sales and exchanges, net | (2) | — |
| Operating income (GAAP) | $139 | $69 |
Free Cash Flow
The following table presents Free cash flow, which is defined as Cash flows from operating activities less Cash paid for additions to property, plant and equipment and Cash paid for software license agreements. Free cash flow is a non-GAAP financial measure which UScellular believes may be useful to investors and other users of its financial information in evaluating liquidity, specifically, the amount of net cash generated by business operations after deducting Cash paid for additions to property, plant and equipment and Cash paid for software license agreements.
| 2023 | 2022 | |
|---|---|---|
| (Dollars in millions) | ||
| Cash flows from operating activities (GAAP) | $866 | $832 |
| Cash paid for additions to property, plant and equipment | (608) | (602) |
| Cash paid for software license agreements | (66) | (22) |
| Free cash flow (Non-GAAP) | $192 | $208 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.